ALX Oncology Holdings Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ALX Oncology Holdings Inc. on March 22, 2021. The report discloses a material event regarding the departure of a principal officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
On March 22, 2021, Steffen Pietzke tendered his resignation as Vice President, Finance and Chief Accounting Officer, effective March 31, 2021. Upon his departure, Peter Garcia, the Company's Chief Financial Officer, will assume the role of principal accounting officer.
Management Commentary and Risks
Management explicitly stated that Mr. Pietzke's resignation was not due to any disagreement with the Company regarding accounting principles, financial statement disclosures, or internal controls. No other risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Confirm the effective date of the resignation is March 31, 2021.
- Verify that Peter Garcia has officially assumed the duties of principal accounting officer.
- Review subsequent filings for any impact on the Company's financial reporting timeline or internal controls.